Johnson & Johnson will pay $5.5 billion to resolve lawsuits alleging its talc products caused ovarian cancer, marking a significant step in concluding years of legal battles.
The settlement covers around 76,000 claims
Jul 28, 2026
09:57 am
What's the storyJohnson & Johnson (J&J) has agreed to a landmark settlement of $5.5 billion, resolving thousands of lawsuits linking its talc products with ovarian cancer.
The settlement covers around 76,000 claims and marks the end of a decade-long legal battle for the company.
Johnson & Johnson proposes $5.5 billion talc settlement to end marathon legal fight
Johnson & Johnson to pay $5.5bn settlement in talc cancer lawsuit
Johnson & Johnson agrees to $5.5 billion settlement for baby powder cancer claims
Johnson & Johnson announces $5.5 billion settlement of talc lawsuits
Johnson & Johnson Proposes $5.5B Talc Settlement to End Marathon Legal Fight
J&J nears end of talc lawsuits with $5.5b deal
Johnson & Johnson announces US$5.5 billion settlement of talc lawsuits
Johnson & Johnson offers $5.5bn to settle talc cancer lawsuits
Johnson & Johnson offers $5.5 billion to settle talc lawsuits
Johnson & Johnson seeks to end decade-long talc litigation with $5.5 billion settlement
Johnson & Johnson has agreed to pay $5.5 billion to tie up remaining lawsuits that claim its talc products caused ovarian cancer.
Landmark deal covers about 76,000 claims and could end contentious, decade-long legal battle
Johnson & Johnson will pay $5.5 billion to settle ovarian cancer claims. This landmark settlement covers nearly all remaining…
Johnson & Johnson announces a $5.5 billion settlement to resolve nearly 69,000 talc-related lawsuits alleging cancer risks.
Remaining lawsuits against the company claim its talc products caused ovarian cancer
Johnson & Johnson said on Monday it would pay an estimated $5.5 billion to resolve tens of thousands of lawsuits alleging its…
